| Drug–protein binding: a critical review of analytical tools K Vuignier, J Schappler, JL Veuthey, PA Carrupt, S Martel Analytical and bioanalytical chemistry 398, 53-66, 2010 | 421 | 2010 |
| Improvement of a capillary electrophoresis/frontal analysis (CE/FA) method for determining binding constants: discussion on relevant parameters K Vuignier, J Schappler, JL Veuthey, PA Carrupt, S Martel Journal of pharmaceutical and biomedical analysis 53 (5), 1288-1297, 2010 | 60 | 2010 |
| Adsorption and recovery issues of recombinant monoclonal antibodies in reversed‐phase liquid chromatography S Fekete, A Beck, E Wagner, K Vuignier, D Guillarme Journal of separation science 38 (1), 1-8, 2015 | 53 | 2015 |
| High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug–plasma protein interactions K Vuignier, D Guillarme, JL Veuthey, PA Carrupt, J Schappler Journal of pharmaceutical and biomedical analysis 74, 205-212, 2013 | 49 | 2013 |
| Characterization of drug–protein interactions by capillary electrophoresis hyphenated to mass spectrometry K Vuignier, JL Veuthey, PA Carrupt, J Schappler Electrophoresis 33 (22), 3306-3315, 2012 | 48 | 2012 |
| Global analytical strategy to measure drug–plasma protein interactions: From high-throughput to in-depth analysis K Vuignier, JL Veuthey, PA Carrupt, J Schappler Drug discovery today 18 (21-22), 1030-1034, 2013 | 41 | 2013 |
| Comparison of various silica‐based monoliths for the analysis of large biomolecules K Vuignier, S Fekete, PA Carrupt, JL Veuthey, D Guillarme Journal of separation science 36 (14), 2231-2243, 2013 | 17 | 2013 |
| Analytical Strategy to Characterize Drug–Plasma Interactions: From High Throughput to In-depth Analysis K Vuignier, JL Veuthey, PA Carrupt, J Schappler CHIMIA International Journal for Chemistry 67 (10), 739-739, 2013 | | 2013 |
| Analytical strategy to characterize drug-protein interactions: from high throughput to in-depth analysis K Vuignier | | 2012 |
